Pharmacodynamics and Drug Development
Perspectives in Clinical Pharmacology
1st Edition
Published on 13. July 1994
Book
Hardback
512 pages
978-0-471-95052-3 (ISBN)
Description
Contains essential facts and concepts spanning many of the important drug classes. Features an authoritative section on general methodology and regulatory issues. The molecular biology and pharmacology of key receptor types are considered along with the detailed pharmacodynamics of a wide range of therapeutic drug groups.
More details
Language
English
Place of publication
New York
United States
Target group
College/higher education
Professional and scholarly
Product notice
sewn/stitched
Cloth over boards
Dimensions
Height: 235 mm
Width: 157 mm
Thickness: 34 mm
Weight
970 gr
ISBN-13
978-0-471-95052-3 (9780471950523)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Persons
Neal R. Cutler is the editor of Pharmacodynamics and Drug Development: Perspectives in Clinical Pharmacology, published by Wiley. John J. Sramek is the editor of Pharmacodynamics and Drug Development: Perspectives in Clinical Pharmacology, published by Wiley.
Content
Partial table of contents:
OVERVIEW OF PHARMACODYNAMICS.
Basic Pharmacodynamic Concepts and Models (R. Wills).
Factors Influencing Variability in Kinetics and Dynamics (P. Narang& R. Li).
General Perspectives on the Role of Metabolite in Pharmacokineticsand Pharmacodynamics (R. Seifert).
Regulatory Perspective: The Role of Pharmacokinetics andPharmacodynamics (L. Lesko & R. Williams).
APPLICATION OF PHARMACODYNAMICS IN SELECTED THERAPEUTICDOMAINS.
Theoretical Models for Developing Anxiolytics (P. Nickell & T.Uhde).
Pharmacodynamics of Antipsychotic Drugs in Schizophrenia (J. Sramek& G. Simpson).
Antihypertensive Drugs (L. Prisant & A. Carr).
Pharmacodynamics of Antineoplastic Agents (G. Rosner & M.Ratain).
Virology and Antiviral Drug Development (M. Amantea, et al.).
FRONTIERS IN PHARMACODYNAMICS: INSIGHT FROM MOLECULARAPPROACHES.
Muscarinic Receptors: Pharmacological Subtypes, Structure, Functionand Regulation (L. Mei, et al.).
Serotonin Receptor Subtypes (D. Pritchett).
Index.
OVERVIEW OF PHARMACODYNAMICS.
Basic Pharmacodynamic Concepts and Models (R. Wills).
Factors Influencing Variability in Kinetics and Dynamics (P. Narang& R. Li).
General Perspectives on the Role of Metabolite in Pharmacokineticsand Pharmacodynamics (R. Seifert).
Regulatory Perspective: The Role of Pharmacokinetics andPharmacodynamics (L. Lesko & R. Williams).
APPLICATION OF PHARMACODYNAMICS IN SELECTED THERAPEUTICDOMAINS.
Theoretical Models for Developing Anxiolytics (P. Nickell & T.Uhde).
Pharmacodynamics of Antipsychotic Drugs in Schizophrenia (J. Sramek& G. Simpson).
Antihypertensive Drugs (L. Prisant & A. Carr).
Pharmacodynamics of Antineoplastic Agents (G. Rosner & M.Ratain).
Virology and Antiviral Drug Development (M. Amantea, et al.).
FRONTIERS IN PHARMACODYNAMICS: INSIGHT FROM MOLECULARAPPROACHES.
Muscarinic Receptors: Pharmacological Subtypes, Structure, Functionand Regulation (L. Mei, et al.).
Serotonin Receptor Subtypes (D. Pritchett).
Index.